Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Approvable letter for Zenvia

Nov. 2, 2006

Emerging natural products for the treatment of neurological disorders: Part II

Nov. 2, 2006

Phase II findings for U-101 in chronic pelvic pain of bladder origin

Nov. 2, 2006

NG2-73 begins phase II study in chronic insomnia patients

Nov. 2, 2006

Satori Pharmaceuticals' SPI-014 exhibits Abeta42-lowering activity in vitro and in vivo

Nov. 2, 2006

Novel cannabinoid agonists reported by Adolor

Nov. 2, 2006

Recent Pfizer patent describes new dopamine D2 receptor ligands for schizophrenia

Oct. 31, 2006

Emerging natural products for the treatment of neurological disorders: Part I

Oct. 31, 2006

Nicotinamide protects against axonal degeneration in MS model / News in Context

Oct. 31, 2006

Strattera improves ADHD symptoms in subjects with reading disorder

Oct. 31, 2006

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...